Expression of Bfl-1 in normal and tumor tissues: Bfl-1 overexpression in cancer is attributable to its preferential expression in infiltrating inflammatory cells

Hum Pathol. 1998 Jul;29(7):723-8. doi: 10.1016/s0046-8177(98)90282-9.

Abstract

Bfl-1, a member of the Bcl-2 gene family, blocks p53-mediated apoptosis and has oncogenic transforming activity. In normal tissues, the transcript of Bfl-1 is expressed abundantly in bone marrow and at a low level in several other tissues. In previous experiments, elevated expression of Bfl-1 was observed by Northern analysis of stomach cancer samples. To study the role of Bfl-1 in normal cell development and in tumorigenesis, we have analyzed the expression of Bfl-1 in normal and tumor tissues by the in situ hybridization technique. The Bfl-1 transcript was detected in the white pulp of the spleen and in the germinal center of lymphatic tissues. In tumor tissues, its expression was preferentially detected in infiltrating inflammatory cells rather than in cancer cells, suggesting that Bfl-1 is not involved in tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colonic Neoplasms / metabolism*
  • Colonic Neoplasms / pathology
  • Eosinophils / metabolism*
  • Eosinophils / pathology
  • Gastric Mucosa / cytology
  • Gastric Mucosa / metabolism
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • In Situ Hybridization
  • Lymphocytes, Tumor-Infiltrating / metabolism*
  • Lymphocytes, Tumor-Infiltrating / pathology
  • Lymphoid Tissue / cytology
  • Lymphoid Tissue / metabolism*
  • Minor Histocompatibility Antigens
  • Neutrophils / metabolism*
  • Neutrophils / pathology
  • Proteins / metabolism*
  • Proto-Oncogene Proteins c-bcl-2*
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology

Substances

  • BCL2-related protein A1
  • Minor Histocompatibility Antigens
  • Proteins
  • Proto-Oncogene Proteins c-bcl-2